Segall Bryant & Hamill’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,545
| Closed | -$564K | – | 544 |
|
|
2023
Q2 | $564K | Sell |
3,545
-12,500
| -78% | -$2.02M | 0.01% | 552 |
|
|
2023
Q1 | $2.54M | Sell |
16,045
-167
| -1% | -$25K | 0.03% | 408 |
|
|
2022
Q4 | $2.27M | Sell |
16,212
-537
| -3% | -$76.2K | 0.03% | 408 |
|
|
2022
Q3 | $2.15M | Sell |
16,749
-330
| -2% | -$47.6K | 0.03% | 419 |
|
|
2022
Q2 | $2.41M | Sell |
17,079
-247
| -1% | -$35.3K | 0.03% | 408 |
|
|
2022
Q1 | $2.41M | Sell |
17,326
-10,029
| -37% | -$1.54M | 0.02% | 417 |
|
|
2021
Q4 | $4.76M | Sell |
27,355
-1,355
| -5% | -$226K | 0.04% | 326 |
|
|
2021
Q3 | $4.76M | Buy |
28,710
+888
| +3% | +$153K | 0.05% | 339 |
|
|
2021
Q2 | $4.99M | Sell |
27,822
-11,002
| -28% | -$2.01M | 0.05% | 334 |
|
|
2021
Q1 | $7.51M | Sell |
38,824
-19,204
| -33% | -$3.7M | 0.07% | 259 |
|
|
2020
Q4 | $11.7M | Sell |
58,028
-57,135
| -50% | -$11.8M | 0.13% | 176 |
|
|
2020
Q3 | $24.2M | Sell |
115,163
-8
| -0% | -$1.78K | 0.33% | 78 |
|
|
2020
Q2 | $25.3M | Sell |
115,171
-5,204
| -4% | -$1.04M | 0.42% | 63 |
|
|
2020
Q1 | $20.9M | Buy |
120,375
+12,165
| +11% | +$2.01M | 0.42% | 60 |
|
|
2019
Q4 | $16.6M | Buy |
108,210
+21,855
| +25% | +$3.27M | 0.26% | 97 |
|
|
2019
Q3 | $13.1M | Buy |
86,355
+83,651
| +3,094% | +$13.2M | 0.2% | 130 |
|
|
2019
Q2 | $415K | Sell |
2,704
-630
| -19% | -$96.2K | 0.01% | 690 |
|
|
2019
Q1 | $534K | Buy |
3,334
+90
| +3% | +$14K | 0.01% | 650 |
|
|
2018
Q4 | $500K | Sell |
3,244
-305
| -9% | -$47.5K | 0.01% | 646 |
|
|
2018
Q3 | $534K | Buy |
3,549
+226
| +7% | +$32.1K | 0.01% | 666 |
|
|
2018
Q2 | $449K | Sell |
3,323
-1,128
| -25% | -$139K | 0.01% | 687 |
|
|
2018
Q1 | $592K | Sell |
4,451
-445
| -9% | -$59.8K | 0.01% | 407 |
|
|
2017
Q4 | $728K | Buy |
4,896
+1,021
| +26% | +$139K | 0.02% | 373 |
|
|
2017
Q3 | $511K | Sell |
3,875
-336
| -8% | -$45.1K | 0.01% | 426 |
|
|
2017
Q2 | $561K | Buy |
+4,211
| New | +$568K | 0.01% | 413 |
|
|
2017
Q1 | – | Sell |
-1,933
| Closed | -$232K | – | 551 |
|
|
2016
Q4 | $232K | Buy |
1,933
+83
| +4% | +$9.79K | 0.01% | 505 |
|
|
2016
Q3 | $232K | Sell |
1,850
-700
| -27% | -$91.7K | 0.01% | 509 |
|
|
2016
Q2 | $353K | Sell |
2,550
-250
| -9% | -$32.4K | 0.01% | 462 |
|
|
2016
Q1 | $353K | Hold |
2,800
| – | – | 0.01% | 458 |
|
|
2015
Q4 | $355K | Sell |
2,800
-360
| -11% | -$44.7K | 0.01% | 453 |
|
|
2015
Q3 | $365K | Hold |
3,160
| – | – | 0.01% | 456 |
|
|
2015
Q2 | $329K | Hold |
3,160
| – | – | 0.01% | 474 |
|
|
2015
Q1 | $349K | Hold |
3,160
| – | – | 0.01% | 468 |
|
|
2014
Q4 | $329K | Hold |
3,160
| – | – | 0.01% | 476 |
|
|
2014
Q3 | $303K | Buy |
3,160
+110
| +4% | +$9.95K | 0.01% | 488 |
|
|
2014
Q2 | $279K | Sell |
3,050
-260
| -8% | -$23.3K | 0.01% | 505 |
|
|
2014
Q1 | $291K | Sell |
3,310
-775
| -19% | -$68K | 0.01% | 518 |
|
|
2013
Q4 | $379K | Buy |
+4,085
| New | +$368K | 0.01% | 480 |
|
Other funds holding CLX
Segall Bryant & Hamill's CLX Position: Q3 2023 in Review
Segall Bryant & Hamill sold out of Clorox (CLX) in Q3 2023, closing a stake of 3,545 shares — an estimated $564K sold.
Segall Bryant & Hamill first reported a position in CLX in Q4 2013 and held it in 38 quarters. The position peaked at $25.3M in Q2 2020. 1,064 funds tracked by Wall St. Rank hold CLX as of Q3 2023.
- Segall Bryant & Hamill reported no remaining Clorox position as of Q3 2023 after selling out during the quarter.
- Segall Bryant & Hamill sold 3,545 Clorox shares in Q3 2023, an estimated $564K.
- Segall Bryant & Hamill first reported a position in Clorox in Q4 2013 and held it in 38 quarters.
- Segall Bryant & Hamill's Clorox position peaked at $25.3M in Q2 2020.
- 1,064 funds tracked by Wall St. Rank held Clorox as of Q3 2023.
Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.